Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of chloroquine phosphate gel in cutaneous warts and anogenital condyloma acuminatum
CTR20201345Phase 2Completed
- Sponsor
- Capbio
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chloroquine in anogenital warts, verruca, flat wart, sponsored by Capbio. Started Dec 2020; status: completed.
02
Drugs
chloroquine
03
Conditions
anogenital wartsverrucaflat wart
Beyond the preview
Go deeper on CTR20201345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201345.